Psychiatry Research: Neuroimaging
Volume 182, Issue 2 , Pages 111-116 , 30 May 2010

Chronic and treatment-resistant depression: A study using arterial spin labeling perfusion MRI at 3Tesla

  • Bérengère Duhameau

      Affiliations

    • Department of Psychiatry, SHU Centre Hospitalier Guillaume Régnier, CHU Rennes, France
    • URU 425 Comportement et Noyaux Gris Centraux, CHU Rennes, Université Rennes I, France
    • Corresponding Author InformationCorresponding author. Service Hospitalo-Universitaire de Psychiatrie d'Adulte, Centre Hospitalier Guillaume Régnier, 108 avenue du Général Leclerc, 35703 Rennes, France. Tel.: +33 2 99 33 39 37; fax: +33 2 99 33 39 72.
    • ,
  • Jean-Christophe Ferré

      Affiliations

    • Department of Neuroradiology, CHU Rennes, France
    • INSERM, U746, Faculté de Médecine CS34317, F-35043, Rennes, France
    • INRIA, VisAGeS Unité/Projet, F-35042, Rennes, France
    • Université Rennes I, CNRS, UMR6074, IRISA, F-35042, Rennes, France
    • ,
  • Pierre Jannin

      Affiliations

    • INSERM, U746, Faculté de Médecine CS34317, F-35043, Rennes, France
    • INRIA, VisAGeS Unité/Projet, F-35042, Rennes, France
    • Université Rennes I, CNRS, UMR6074, IRISA, F-35042, Rennes, France
    • ,
  • Jean-Yves Gauvrit

      Affiliations

    • Department of Neuroradiology, CHU Rennes, France
    • INSERM, U746, Faculté de Médecine CS34317, F-35043, Rennes, France
    • INRIA, VisAGeS Unité/Projet, F-35042, Rennes, France
    • Université Rennes I, CNRS, UMR6074, IRISA, F-35042, Rennes, France
    • ,
  • Marc Vérin

      Affiliations

    • URU 425 Comportement et Noyaux Gris Centraux, CHU Rennes, Université Rennes I, France
    • Department of Neurology, CHU Rennes, France
    • ,
  • Bruno Millet

      Affiliations

    • Department of Psychiatry, SHU Centre Hospitalier Guillaume Régnier, CHU Rennes, France
    • URU 425 Comportement et Noyaux Gris Centraux, CHU Rennes, Université Rennes I, France
    • ,
  • Dominique Drapier

      Affiliations

    • Department of Psychiatry, SHU Centre Hospitalier Guillaume Régnier, CHU Rennes, France
    • URU 425 Comportement et Noyaux Gris Centraux, CHU Rennes, Université Rennes I, France

Received 14 October 2008 ,Revised 23 December 2009 ,Accepted 14 January 2010.

References 

  1. Ballmaier M, Toga AW, Blanton RE, Sowell ER, Lavretsky H, Peterson J, et al. Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRI-based parcellation of the prefrontal cortex. American Journal of Psychiatry. 2004;161:99–108
  2. Baxter LR, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Archives of General Psychiatry. 1989;46:243–250
  3. Botteron KN, Raichle ME, Drevets WC, Heath AC, Todd RD. Volumetric reduction in left subgenual prefrontal cortex in early onset depression. Biological Psychiatry. 2002;51:342–344
  4. Brody AL, Barsom MW, Bota RG, Saxena S. Prefrontal–subcortical and limbic circuit mediation of major depressive disorder. Seminars in Clinical Neuropsychiatry. 2001;6:102–112
  5. Buchsbaum MS, Wu J, Siegel BV, Hackett E, Trenary M, Abel L, et al. Effect of sertraline on regional metabolic rate in patients with affective disorder. Biological Psychiatry. 1997;41:15–22
  6. Clark CP, Frank LR, Brown GG. Sleep deprivation, EEG, and functional MRI in depression: preliminary results. Neuropsychopharmacology. 2001;25:S79–S84
  7. Clark CP, Brown GG, Frank L, Thomas L, Sutherland AN, Gillin JC. Improved anatomic delineation of the antidepressant response to partial sleep deprivation in medial frontal cortex using perfusion-weighted functional MRI. Psychiatry Research: Neuroimaging. 2006;146:213–222
  8. Detre JA, Alsop DC. Perfusion magnetic resonance imaging with continuous arterial spin labeling: methods and clinical applications in the central nervous system. European Journal of Radiology. 1999;30:115–124
  9. Doraiswamy PM, MacFall J, Krishnan KR, O'Connor C, Wan X, Benaur M, et al. Magnetic resonance assessment of cerebral perfusion in depressed cardiac patients: preliminary findings. American Journal of Psychiatry. 1999;156:1641–1643
  10. Dougherty DD, Weiss AP, Cosgrove GR, Alpert NM, Cassem EH, Nierenberg AA, et al. Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression. Journal of Neurosurgery. 2003;99:1010–1017
  11. Drevets WC. Neuroimaging studies of mood disorders. Biological Psychiatry. 2000;48:813–829
  12. Drevets WC. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Current Opinion in Neurobiology. 2001;11:240–249
  13. Drevets WC, Videen TO, Price JL, Preskorn SH, Carmichael ST, Raichle ME. A functional anatomical study of unipolar depression. Journal of Neuroscience. 1992;12:3628–3641
  14. Drevets WC, Price JL, Simpson JR, Todd RD, Reich T, Vannier M, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 1997;386:824–827
  15. Drevets WC, Bogers W, Raichle ME. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. European Neuropsychopharmacology. 2002;12:527–544
  16. Du AT, Jahng GH, Hayasaka S, Kramer JH, Rosen HJ, Gorno-Tempini ML, et al. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology. 2006;67:1215–1220
  17. Edelman RR, Chen Q. EPISTAR MRI: multislice mapping of cerebral blood flow. Magnetic Resonance in Medicine. 1998;40:800–805
  18. Fava M. Diagnosis and definition of treatment-resistant depression. Biological Psychiatry. 2003;53:649–659
  19. Feng CM, Narayana S, Lancaster JL, Jerabek PA, Arnow TL, Zhu F, et al. CBF changes during brain activation: fMRI vs. PET. Neuroimage. 2004;22:443–446
  20. George MS, Ketter TA, Parekh PI, Rosinsky N, Ring HA, Pazzaglia PJ, et al. Blunted left cingulate activation in mood disorder subjects during a response interference task (the Stroop). Journal of Neuropsychiatry and Clinical Neurosciences. 1997;9:55–63
  21. Golay X, Petersen ET. Arterial spin labeling: benefits and pitfalls of high magnetic field. Neuroimaging Clinics of North America. 2006;16:259–268
  22. Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S, et al. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Archives of General Psychiatry. 2004;61:34–41
  23. Greicius MD, Flores BH, Menon V, Glover GH, Solvason HB, Kenna H, et al. Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biological Psychiatry. 2007;62:429–437
  24. Guy W. In: ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: National Institute of Mental Health; 1976;p. 218–222revised
  25. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry. 1960;23:56–62
  26. Hirayasu Y, Shenton ME, Salisbury DF, Kwon JS, Wible CG, Fischer IA, et al. Subgenual cingulate cortex volume in first-episode psychosis. American Journal of Psychiatry. 1999;156:1091–1093
  27. Liotti M, Mayberg HS, McGinnis S, Brannan SL, Jerabek P. Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression. American Journal of Psychiatry. 2002;159:1830–1840
  28. Lupo JM, Lee MC, Han ET, Cha S, Chang SM, Berger MS, et al. Feasibility of dynamic susceptibility contrast perfusion MR imaging at 3T using a standard quadrature head coil and eight-channel phased-array coil with and without SENSE reconstruction. Journal of Magnetic Resonance Imaging. 2006;24:520–529
  29. Maffei C, Fossati A, Agostoni I, Barraco A, Bagnato M, Deborah D, et al. Interrater reliability and internal consistency of the structured clinical interview for DSM-IV axis II personality disorders (SCID-II), version 2.0. Journal of Personality Disorder. 1997;11:279–284
  30. Malizia AL. The frontal lobes and neurosurgery for psychiatric disorders. Journal of Psychopharmacology. 1997;11:179–187
  31. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. In:  Bellack R,  Karasu B editor. Geriatric Psychiatry. New York: Grune & Stratton; 1976;p. 77–121
  32. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL, et al. Cingulate function in depression: a potential predictor of treatment response. Neuroreport. 1997;8:1057–1061
  33. Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA, et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. American Journal of Psychiatry. 1999;156:675–682
  34. Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S, et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biological Psychiatry. 2000;48:830–843
  35. Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, et al. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45:651–660
  36. Mottaghy FM, Keller CE, Gangitano M, Ly J, Thall M, Parker JA, et al. Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients. Psychiatry Research: Neuroimaging. 2002;115:1–14
  37. Nobler MS, Oquendo MA, Kegeles LS, Malone KM, Campbell CC, Sackeim HA, et al. Decreased regional brain metabolism after ECT. American Journal of Psychiatry. 2001;158:305–308
  38. Nurnberger JI, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Archives of General Psychiatry. 1994;51:849–859discussion 863–844
  39. Pruessmann KP. Parallel imaging at high field strength: synergies and joint potential. Topics in Magnetic Resonance Imaging. 2004;15:237–244
  40. Seminowicz DA, Mayberg HS, McIntosh AR, Goldapple K, Kennedy S, Segal Z, et al. Limbic-frontal circuitry in major depression: a path modeling metanalysis. Neuroimage. 2004;22:409–418
  41. Tekin S, Cummings JL. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. Journal of Psychosomatic Research. 2002;53:647–654
  42. Thase ME. The need for clinically relevant research on treatment-resistant depression. Journal of Clinical Psychiatry. 2001;62:221–224
  43. Thase ME, Rush AJ. When at first you don't succeed: sequential strategies for antidepressant nonresponders. Journal of Clinical Psychiatry. 1997;58(Suppl 13):23–29
  44. Thase ME, Friedman ES, Howland RH. Management of treatment-resistant depression: psychotherapeutic perspectives. Journal of Clinical Psychiatry. 2001;62(Suppl 18):18–24
  45. Wang J, Zhang Y, Wolf RL, Roc AC, Alsop DC, Detre JA. Amplitude-modulated continuous arterial spin-labeling 3.0-T perfusion MR imaging with a single coil: feasibility study. Radiology. 2005;235:218–228
  46. Warmuth C, Gunther M, Zimmer C. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. Radiology. 2003;228:523–532
  47. Wintermark M, Sesay M, Barbier E, Borbely K, Dillon WP, Eastwood JD, et al. Comparative overview of brain perfusion imaging techniques. Stroke. 2005;36:e83–e99
  48. Wolf RL, Alsop DC, McGarvey ML, Maldjian JA, Wang J, Detre JA. Susceptibility contrast and arterial spin labeled perfusion MRI in cerebrovascular disease. Journal of Neuroimaging. 2003;13:17–27
  49. Ye FQ, Berman KF, Ellmore T, Esposito G, van Horn JD, Yang Y, et al. H(2)(15)O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans. Magnetic Resonance in Medicine. 2000;44:450–456

PII: S0925-4927(10)00034-X

doi: 10.1016/j.pscychresns.2010.01.009

Psychiatry Research: Neuroimaging
Volume 182, Issue 2 , Pages 111-116 , 30 May 2010

Article Tools

* Image Usage & Resolution